Additional file 1: of Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study) - de research portal van de Rijksuniversiteit Groningen

Description

Data on adherence, persistence, self-efficacy, HRQoL, gender and disease duration. (XLSX 25 kb)

Datum van beschikbaarheid	14-mrt.-2017
Uitgever	University of Groningen

Contact

[email protected]

DOI
10.6084/m9.figshare.c.3717133_d1.v1

1 Article

Glatiramer acetate treatment persistence but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: A prospective web-based patient-centred study (CAIR study)
Jongen, P. J., Lemmens, W. A., Hoogervorst, E. L. & Donders, R., 14-mrt.-2017, In: Health and Quality of Life Outcomes. 15, 50, 9 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand
8 Citaten (Scopus)

349 Downloads (Pure)

Citeer dit

DataSetCite

Jongen, S. (Contributor), Lemmens, W. A. (Contributor), Hoogervorst, E. L. (Contributor), Donders, R. (Contributor) (14-mrt.-2017). Additional file 1: of Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study). University of Groningen. 10.6084/m9.figshare.c.3717133_d1.v1

Additional file 1: of Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study)

Description

Contact

DOI

Onderzoekersoutput

Glatiramer acetate treatment persistence but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: A prospective web-based patient-centred study (CAIR study)

Citeer dit